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This thesis explored the influence of culture environment on proliferation and 
hepatic differentiation of fetal liver cells.  Specifically, signals provided by soluble 
factors and culture substrates were examined.  Comparison of a variety of culture 
medium conditions suggested that hepatocyte growth factor (HGF) is required 
throughout the culture period to induce the differentiation of liver stem cells into 
hepatic precursors, and to ensure the continual proliferation of stem cells and their 
progeny.  On the other hand, timing of the addition of maturation-inducing factors 
such as oncostatin M (OSM) determines the kinetics of cell maturation.  In the 
presence of HGF, adding OSM from the beginning results in concurrent growth and 
differentiation.  In addition, the constant presence of protective agents such as ascorbic 
acid helps to enhance cell survival, leading to improved cell expansion and hepatocyte 
functions.  Based on these findings, a modified culture medium was developed to 
achieve both optimal growth and differentiation.  Cell expansion in this medium was 
about 2 fold of that under other tested conditions, whereas the specific albumin 
secretion rate was 2 - 3 times of the maximal values obtained with other conditions.  
Subsequently, characterization of fetal liver cells cultured on a variety of three-
dimensional (3D) scaffolds, including decellularized liver matrices, collagen scaffolds, 
and poly(lactic-co-glycolic acid) (PLGA) scaffolds, showed that the cellular responses 
to soluble signals are modulated by culture substrates.  Experiments using scaffolds 
prepared from blends of PLGA(50:50) and polycaprolactone (PCL) further suggested 
that cell expansion requires rigid and porous scaffolds, whereas differentiation is 
  
enhanced on more pliable substrates.  Together, these results demonstrated that the in 
vitro behavior of fetal liver cells is regulated by both the soluble and physical cues 
present in their microenvironment.  Furthermore, cell growth and differentiation are 
influenced not only by the regulatory factors that are present, but also by the timing of 
their addition.  These findings would help to develop a culture system that employs 
dynamic integration of biochemical and substrate-related signals to control the growth 
and differentiation kinetics of fetal liver cells.  They may also provide a foundation for 
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1.1 LIVER  FUNCTIONS 
The liver, the largest gland in the body, is vital to the body’s metabolism and 
detoxification activities.  The liver’s functions are carried out primarily by its 
parenchymal cells – hepatocytes, which perform an astonishingly large number of 
activities.  Below is a brief review of the key functions of the liver. 
 
Amino acid metabolism 
The liver plays a central role in amino acid metabolism 
1.  Amino acids in the 
plasma are removed by hepatocytes for protein synthesis or energy production.  In 
addition, the liver is the principal site for the synthesis of non-essential amino acids 
and for the re-amination of most essential amino acids.  Furthermore, it is a major site 
for amino acid breakdown.  The majority of the nitrogen released from amino acid 
catabolism, in the form of highly toxic ammonia, is converted to urea by hepatocytes 
via the urea cycle that occurs almost exclusively in the liver. 
 
Protein synthesis 
Proteins synthesized by hepatocytes are predominantly plasma proteins, and 
account for approximately 15% of the body’s total protein production 
2.  Albumin, the 
major plasma protein, is synthesized almost exclusively by the liver.  In addition, 
hepatocytes are responsible for the production of transport proteins such as transferrin, 
all but factor VIII of the coagulation cascade components, many of the proteins 
1   2




Another critical function of the liver is to maintain the plasma carbohydrate 
levels within a narrow, normal range 
3, 4.  Excess glucose and fructose entering the 
blood after a meal are removed by hepatocytes, which convert the sugars to glycogen 
(glycogenesis) or other metabolites such as fatty acids and lactate.  During fasting, the 
liver becomes an essential source of energy for other tissues by exporting glucose back 
into the blood.  Initially, glucose is generated via depolymerization of the glycogen 
stored within hepatocytes (glycogenolysis).  When hepatic glycogen reserves become 
exhausted, glucose is synthesized by hepatocytes from amino acids, lactate, pyruvate, 
and glycerol (gluconeogenesis). 
 
Xenobiotic biotransformation 
The liver is pivotal in the metabolism of most drugs and related xenobiotics.  
These compounds, often lipophilic, are rendered hydrophilic by hepatocytes via two 
phases of biotransformation 
5.  In phase I, the compounds are converted to more polar 
metabolites for excretion by oxidation, reduction, or hydrolysis.  Compounds that 
cannot be effectively excreted through phase I reactions are conjugated with an 
endogenous molecule such as glucuronic acid in a phase II reaction.  Major enzymes 
involved in these reactions include the cytochrome P-450 superfamily that mediate 
phase I oxidation reactions, as well as uridine diphosphate (UDP)-glucoronyl 
transferases and glutathione S-transferases that catalyze phase II reactions. 
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Lipid metabolism 
The liver plays a major role in lipid metabolism 
2.  Hepatocytes are capable of 
synthesizing cholesterol.  The cholesterol is packaged into lipoproteins and secreted 
into the blood stream, or excreted via the biliary system.  Additionally, the liver is the 
major site for synthesis of fatty acids, triglycerides, phospholipids, and liporoteins.  
Triglycerides formed in the liver are either packaged into lipoproteins for export or 
metabolized within hepatocytes for energy production. 
 
Bile acid synthesis 
Hepatocytes are critical to the synthesis, secretion, and cycling of bile acids, 
and are the only cells that can enzymatically convert cholesterol to bile acids 
6.  The 
synthesis of bile acids helps to maintain cholesterol homeostasis, as it is a major route 
for eliminating cholesterol in the body.  Another major function of bile acids is the 
emulsification, solubilization, and transport of dietary lipids, which enhances their 
absorption in the small intestine. 
 
Bilirubin removal 
The liver is responsible for disposing bilirubin, a toxic product derived from 
the breakdown of haem-containing compounds, predominantly haemoglobin from 
senescent erythocytes 
7.  Bilirubin formed by phagocytic cells is released into the 
blood stream and transported by albumin.  It is efficiently removed from the plasma by 
hepatocytes.  In hepatocytes, the lipid-soluble bilirubin is converted to a water-soluble 
compound by conjugation with glucuronic acid.  The conjugated bilirubin is secreted 
into the canaliculus as part of bile, and ultimately eliminated upon further reactions. 
 
 
   4
1.2 ADULT  HEPATOCYTES 
Although liver transplantation is the only effective treatment of end-stage liver 
diseases at present, severe donor shortage calls for the development of alternative 
treatment approaches 
8.  Due to the diverse and complex nature of liver functions, it 
has not been possible to support a failing liver with purely mechanical systems 
9, 10.  
Hepatocytes, the chief functional cells of the liver, have therefore become a prime 
component of cell therapy and tissue engineering approaches to liver repair and 
regeneration.  These alternative strategies that are being developed include 1) 
hepatocyte transplantation; 2) implantable tissue constructs constituted by hepatocytes 
and their supportive scaffolds; 3) extracorporeal liver support systems 
8. 
In order to achieve clinical efficacy, all of these approaches require a sufficient 
mass of functional hepatocytes 
11.  This has proven to be a challenge as hepatocytes 
from adult livers are rather difficult to culture 
12, 13.  Although hepatocytes can 
proliferate efficiently in vivo in response to liver damage, they possess low growth 
capacity in vitro 
14-16.  Furthermore, the large array of in vivo functions carried out by 
hepatocytes is mostly lost in culture 
17-20.  These issues limit the quantity and quality 
of hepatocytes available for treatment. 
In the past several decades, the culture conditions of hepatocytes have been 
extensively studied in order to address these issues.  These researches attempted to 
promote the proliferation of hepatocytes or to stabilize their differentiated phenotype 
by manipulating the soluble signals provided by the culture medium 
14, 21, 22, 
homotypic (hepatocyte – hepatocyte) and heterotypic (hepatocyte – non-parenchymal 
cell) cell-cell interactions 
23-26, and cell-matrix interactions 
13, 27-30.  As a result, 
hepatocytes are able to undergo a few rounds of cell divisions under optimized 
conditions 
14.  However, such expansion efficiency is still not enough to meet the 
clinical requirement.  Furthermore, even though hepatocyte functions can be better 
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maintained under certain conditions, a reciprocal control of growth and differentiation 
is often observed 
14, 31, 32.  To date, there has been very limited success in achieving 
both efficient hepatocyte expansion and long-term maintenance of hepatocyte 
functions.  This has significantly impeded the progress of liver cell therapy and liver 
tissue engineering research. 
 
 
1.3  LIVER STEM CELLS AND PROGENITORS 
Due to the difficulty in culturing adult hepatocytes, researchers have looked to 
liver stem cells and progenitors as an alternative cell source.  Compared with adult 
hepatocytes, these cells possess inherently high proliferation potential and are able to 
differentiate into functional hepatocytes under the right conditions.  Furthermore, 
some of these cells are capable of differentiating into both hepatocytes and bile duct 
cells, thus raising the possibility of offering a wider range of liver functions 
33. 
Cells possessing progenitor qualities have been observed in adult liver.  The 
most notable example is the oval cells residing in the periportal region of the liver 
34.  
These cells feature ovoid nucleus, compact cell size, and high nucleus-to-cytoplasm 
ratio.  It has been well documented that oval cells undergo rapid proliferation and 
infiltrate into the liver parenchyma when hepatocyte proliferation is inhibited during 
liver damage.  It has also been suggested that oval cells are at least bipotential, capable 
of differentiation along either the hepatocyte or bile duct lineage.  However, the 
isolation and culture methods of these cells are not well established at present.  In 
addition, it has been reported that the adult liver contains the so-called “small 
hepatocytes”, which appear to be less differentiated and more proliferative than 
mature hepatocytes 
16, 35. 
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Embryonic stem cells develop into hepatocytes during spontaneous 
differentiation 
36, 37.  Recent studies have reported initial success in directing the 
differentiation process so that hepatocytes are preferentially derived 
38-40.  However, it 
remains a challenge to separate the resulting hepatocytic fractions from 
undifferentiated embryonic stem cells that may be tumorigenic in vivo. 
Liver progenitors from extrahepatic sources have also been reported.  
Especially, stem cells derived from the bone marrow (BM), including hematopoietic 
stem cells (HSC), mesenchymal stem cells (MSC), and the so-called MAPC (multi-
potent adult progenitor cells) have been described to “transdifferentiate” into 
hepatocytes both in animal models and in culture 
41-46.  However, at least with regard 
to the in vivo studies, it is still being debated whether the phenotypic change is due to 
true differentiation or the fusion of BM cells with hepatocytes 
47-49. 
Cells in the fetal liver lack many of the functions of mature hepatocytes.  In 
fact, many of the important hepatocyte functions are acquired during perinatal stage or 
post birth (see section 1.4).  On the other hand, cells from fetal livers posses much 
higher proliferation capacity than adult hepatocytes (section 1.4).  Additionally, it has 
been shown in animal models that fetal liver cells readily repopulate diseased liver 
upon transplantation 
50.  Thus, fetal liver cells represent a population with liver 
progenitor qualities.  Compared with some of the other liver progenitors, fetal liver 
cells are easy to isolate and have been cultured successfully for both basic science 
research and clinical studies (section 1.4).  Furthermore, some adult liver progenitors, 
such as oval cells, are thought to resemble progenitors of the fetal liver in both 
phenotype and differentiation behavior 
34, 51, 52.  Therefore, fetal liver cells may 
provide a good model system for developing technologies relevant to the clinical 
applications of liver progenitors. 
 
   7
1.4 FETAL  LIVER  CELLS 
 
1.4.1  Development of the liver 
In mice, liver development initiates on embryonic day 8.5 – 9 (E8.5 – E9).  In 
this initial stage, signals derived from the adjacent cardiac mesoderm, such as 
fibroblast growth factor 1 (FGF1) and FGF2, commit primitive pluripotent 
endodermal stem cells residing in the ventral wall of the foregut endoderm to form the 
liver diverticulum (the primary liver bud) 
53-56. 
Over the next 2 days, cells in the liver bud proliferate rapidly and migrate into 
the surrounding septum transversum 
57.  Signals from the mesenchyme of the septum 
transversum, such as bone morphogenetic proteins (BMPs), further induce the cells to 
form the definitive liver 
58, 59.  The embryonic liver at this stage consist of 1) 
pluripotent liver stem cells; and 2) their progeny, the transitory bipotential progenitors, 
hepatoblasts. 
During E12 – E16, the fetal liver becomes the major site for embryonic 
hematopoiesis after invasion of the hematopoietic stem cells on E10.5 
60, 61.  Hepatic 
stem cells and progenitors, together with other stromal cells, foster the expansion of 
hematopoietic cells and the increase of their lineage diversity 
62-65.  On the other hand, 
hematopoietic cells produce oncostatin M (OSM) that induces the hepatic 
differentiation of hepatoblasts and their progeny 
66. 
In the late fetal and perinatal stages (E16 – E19 or E20 depending on the 
mouse strain), hematopoiesis in the liver diminishes as the hematopoietic cells migrate 
to spleen and bone marrow.  Concomitantly, the liver undergoes a functional switch 
from a hematopoietic microenvironment to a metabolic organ, as many new genes 
related to postnatal liver functions are activated in fetal hepatocytes 
67-69.  The final 
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step of liver maturation in rodents takes place several days post birth (terminal 
differentiation) 
70-73. 
Throughout liver development, liver cells of various developmental stages 
proliferate continuously.  Cell growth declines gradually as the liver matures, and is 
eventually arrested after birth 
74. 
Gene markers have been used to characterize the progression from pluripotent 
endodermal stem cells to mature hepatocytes.  An early gene that signifies the 
differentiation of endodermal stem cells is α-fetoprotein (AFP), which is expressed in 
liver stem cells and hepatoblasts.  Its expression diminishes as the cells develop into 
mature hepatocytes 
75, 76.  Albumin (ALB), which belongs to the albuminoid gene 
superfamily as does AFP, is detectable in hepatoblasts.  Its expression increases as 
hepatic differentiation progresses and reaches maximum in mature hepatocytes 
75, 77.  
Some researchers suggested that cytokeratin 19 (CK19), a protein marker of the bile 
duct cells in the adult liver, is also expressed by the bipotential hepatoblasts and its 
expression is lost as the cells differentiate along the hepatic lineage 
78.  In late 
gestational and perinatal stage, metabolic enzymes such as glucose-6-phosphatase 
(G6Pase) and tyrosine aminotransferase (TAT) begin to be expressed in perinatal 
hepatocytes as they prepare for their postnatal metabolic functions 
67-69.  Other hepatic 
enzymes, such as serine dehydratase (SDH) and tryptophan oxygenase (TO), are not 
induced until the terminal differentiation phase after birth 
70, 72, 73.  Several of the P-
450 isoenzymes are also induced during this period 
71. 
 
1.4.2  Isolation of fetal liver epithelial cells and progenitors 
Enrichment for fetal liver epithelial cells (will be called “fetal liver cells” 
henceforth) has been performed by depleting the hematopoietic cells of the fetal liver.  
Techniques such as panning, magnetic cell sorting (MACS), and FACS (fluorescence 
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activated cell sorter) sorting were applied to remove cells that express blood cell 
markers.  The most commonly used hematopoietic markers were CD45 (leukocyte 
common antigen) and TER119 (an antibody recognizing the glycoprotein A expressed 
on all erythrocytes). 
Several recent studies employed MACS and FACS sorting to purify postulated 
liver stem cells and hepatoblasts via positive selection.  Combining FACS sorting and 
single-cell based assays, Suzuki et al. isolated prospective liver stem cells from E13.5 
mouse fetal liver that express both CD49f and CD29 (α6 and β1 integrin subunits that 
bind to laminin), but not the hematopoietic markers CD45, TER119, and c-Kit 
79, 80.  
Anther cell membrane protein, the cell-cell adhesion glycoprotein E-cadherin, was 
used by Nitou and coworkers to positively select cells with hepatoblast characteristics 
from E12.5 mouse liver 
81.  Miyajima’s group reported that hepatoblasts could be 
isolated from E14.5 mouse livers based on their expression of delta-like leucine zipper 
kinase (Dlk, also known as Pref-1) 
82, 83.  Liv2, a cell surface molecule with unknown 
functions, was reported to be a specific marker for liver stem cells and progenitors 
from E9.5 to E12.5 
84.  These results were unified in a recent study performed by 
Shafritz’s group 
50, which showed that AFP
+/ALB
+ cells in E12.5 mouse liver (about 
2.5% of total cells) possessed progenitor qualities such as the capacities for hepatic 
differentiation and liver repopulation.  These cells were positive for E-cadherin, Liv2, 
and Dlk, and vise versa.  On the other hand, the AFP
+/ALB
+ cells did not express 
hematopoietic markers CD45, TER119, and c-Kit.  Only the expression of Sca-1 was 
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1.5  SCOPE OF THESIS  
As discussed earlier, the development of liver cell therapy and liver tissue 
engineering is hindered by the difficulty in culturing adult hepatocytes.  Unlike 
hepatocytes, liver stem cells and progenitors possess high growth potential.  In vitro 
studies and animal experiments have also demonstrated their ability to differentiate 
into functional hepatocytes and repopulate failing livers.  Therefore, liver stem cells 
and progenitors represent a promising alternative cell source. 
To generate an adequate mass of functional tissue from liver stem cells and 
progenitors for clinical applications, it is necessary to establish a culture system that 
supports their optimal proliferation and differentiation.  To date, although culture 
methods have been developed for some liver progenitors, their effectiveness has not 
been characterized.  Furthermore, due to the diversity of liver diseases and of the 
applied treatment regimes, cultured cells with specific qualifications (such as their 
developmental stage) may be required.  At present, this ability has not been fully 
realized, as the impact of culture environment on liver stem cells and progenitors has 
not been fully explored. 
In order to understand these issues, this thesis chose the fetal liver cells as a 
model.  Compared with other liver stem cells and progenitors, fetal liver cells are 
relatively easy to isolate and culture, and readily differentiate into hepatocytes both in 
vitro and in vivo.  Consequently, the design, execution, and interpretation of 
experiments would be more straightforward. 
Although various methods have been developed to purify liver stem cells and 
progenitors from the fetal liver (see section 1.4.2), it was decided that bulk fetal liver 
cells, depleted of non-adherent hematopoietic cells, would be used in this thesis.  This 
decision was based on several considerations.  First, sophisticated cell purification 
procedure may be too time-consuming and therefore not practical for clinical 
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applications.  Second, preliminary experiments showed that TER119
+/CD45
+ cells 
account for about 65% of the total cells, and TER119
+ cells constitute about 90% of 
the TER119
+/CD45
+ populations (data not shown).  The TER119
+ cells can be easily 
depleted by red blood lysis.  Furthermore, the unlysed erythrocytes and non-adherent 
TER119
-CD45
+ cells in the culture can be effectively removed by changing the culture 
medium.  Therefore, the epithelial cell fraction can be significantly enriched by these 
simple techniques.  Third, even with a pure liver stem cell starting population, the 
resulting culture is likely to be a mixture of cell populations at different developmental 
stages and even of different lineages due to simultaneous cell proliferation and 
differentiation.  Last, it is anticipated that an optimal culture system will selectively 
promote the propagation and differentiation of liver progenitors and their progeny. 
This thesis attempted to explore the influence of culture parameters on growth 
and differentiation of fetal liver cells.  Specifically, signals provided by soluble factors 
and culture substrates were evaluated.  The investigation of soluble factors is 
described in Chapter 2.  The study was designed to examine the effectiveness of 
currently used culture medium formulations, to characterize the effect of various 
soluble factors on the growth and differentiation dynamics of fetal liver cells, and to 
develop an optimal medium formulation based on these findings.  Results from this 
study would be applicable to all three categories of liver cell therapy and liver tissue 
engineering, namely cell transplantation, implantable cell/scaffold composites, and 
extracorporeal liver support systems.  To date, the scaffold design requirement for 
fetal liver cell culture has not been defined.  Therefore, Chapter 3 and Chapter 4 
focused on the three-dimensional culture of fetal liver cells under the medium 
condition developed in Chapter 2.  In Chapter 3, representative 3D scaffolds currently 
used in liver tissue engineering were assessed regarding their effectiveness in 
supporting fetal liver cell cultures.  This study was intended as a general survey in 
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order to obtain information on scaffold properties that are possibly crucial to the 
development of fetal liver cells.  Based on results from Chapter 3, a more detailed 
study was performed in Chapter 4 to investigate the impact of scaffold properties, in 
particular the bulk properties such as degradation behavior and mechanical 
characteristics.  Findings from Chapter 3 and 4 would be relevant to the design of 
implantable or extracorporal devices, but may also provide insights on how to improve 
and/or control the cell behavior for cell transplantation purpose. 
It is expected that findings from this thesis would help to improve the current 
culture technologies for fetal liver cells in that cell expansion and maturation can not 
only be maximized but can also be controlled.  Furthermore, it is anticipated that these 
findings could be extended to the applications of other liver stem cells and 
progenitors. 
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 CHAPTER 2 




In order to generate a large number of functional hepatocytes from fetal liver 
cells, it is necessary to establish a culture system that supports their optimal 
proliferation and maturation.  The methods established for fetal liver cells would also 
provide a foundation for developing culture techniques for other liver progenitors. 
Some of the factors that can influence adult hepatocytes also exert regulatory 
effects on fetal liver cells.  For example, hepatocyte growth factor (HGF), whose 
combination with epidermal growth factor (EGF) has the most mitogenic effect on 
adult hepatocytes 
1, was found to be critical for the proliferation of hepatic stem cells 
and hepatoblasts 
2-4.  Dexamethasone, a synthetic glucocorticoid, is a key culture 
component that improves the viability of mature hepatocytes and preserves their 
functions 
1, 5.  In the fetal liver, dexamethasone suppresses the expression of α-
fetoprotein (AFP) and up-regulates albumin synthesis 
6.  In culture, it induces E12.5 
fetal liver cells to acquire characteristics of perinatal hepatocytes, as demonstrated by 
the expression of glucose-6-phosphatase (G6Pase) and tyrosine amino transferase 
(TAT) 
7. 
Other molecules have been found to play roles in fetal liver development.  
Most notably, oncostatin M (OSM), a member of the interleukin-6 (IL-6) family, was 
shown to be a potent stimulator of the maturation of fetal liver cells along the 
hepatocytic lineage 
8, 9.  Dexamethasone is absolutely required for the actions of OSM, 
and augments its effects in a dose-dependent fashion, in the range of 0 to 1 µM 
8.    
The maturation of fetal liver cells induced by OSM is further enhanced by the 
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presence of dimethylsulfoxide (DMSO) and nicotinamide 
10, two pivotal factors that 
extend the survival, DNA synthesis, and functional preservation of adult hepatocytes 
in culture 
1, 11-14. 
Fetal liver cell culture media reported in previous studies took advantage of 
these findings as well as the existing technology developed for adult hepatocyte 
cultures.  Basal media that have been used ranged from standard formulations such as 
DMEM and DMEM/F12 to those specifically designed for long-term culture of adult 
hepatocytes, such as Williams’ E medium 
15 and the chemically defined Block’s 
medium 
1.  These basal media were supplemented with various components that are 
commonly required for the well being of many cell types, including serum or bovine 
albumin, L-glutamine, non-essential amino acids, and insulin.  In addition, compounds 
that regulate fetal liver cells, such as dexamethasone and nicotinamide, were often 
supplied.  Finally, depending on the purpose of the experiment, factors that regulate 
the growth or differentiation of fetal liver cells were applied.  Typically, EGF and 
HGF were added to stimulate growth, whereas OSM was used to induce maturation. 
Some researchers adopted a two-step approach in attempts to achieve both 
maximal proliferation and maturation 
16, 17.  In this case, the fetal liver cells first 
underwent expansion in a growth-stimulating medium.  Subsequently, they were 
induced to differentiate under a second condition that encouraged maturation and often 
reciprocally repressed growth.  In other studies, a single medium combining the 
mitogens and differentiation factors were used for the whole culture period 
18. 
Although a wide variety of fetal liver cell culture media have been described, 
there has been no direct comparison of their effectiveness.  Nor has the kinetics of cell 
growth and maturation been delineated under complex culture conditions that combine 
growth- and differentiation-stimulating factors.  Detailed studies that address these 
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issues will not only help to improve the current culture methods, but also provide 
insights on how to control the growth and differentiation of fetal liver cells. 
In this study, three representative medium conditions were directly compared.  
The first medium, containing HGF and EGF as the key regulatory factors, has been 
used to support the clonal expansion of liver stem cells isolated from E13.5 mouse 
livers 
2, 3.  The second formulation was designed to induce the morphological and 
functional maturation of E14.5 fetal liver cells based on the use of OSM, DMSO, high 
concentration of dexamethasone, and the basal medium Williams’ E 
10.  The third 
condition, a two-step approach, combined the first two media in a sequential manner 
to stimulate both growth and differentiation.  Based on these results, the medium 
formulation was further modified to achieve both optimal growth and differentiation.  
The underlying mechanisms of the growth and differentiation responses to the tested 
conditions were also discussed. 
 
 
2.2  MATERIALS AND METHODS 
 
2.2.1 Materials 
Mice used in this study were from The Jackson Laboratory (Bar Harbor, 
Maine).  Trypsin stock solution, calcium/magnesium-free Dulbecco’s phosphate-
buffered saline (DPBS), antibiotic-antimycotic, L-glutamine, non-essential amino 
acids, all basal culture media, human EGF, Trypsin/EDTA, as well as fetal bovine 
serum (FBS) used in cell trypsinization and MTS assays were purchased from 
Invitrogen Gibco (Grand Island, NY).  FBS used for fetal liver cell processing and 
cultures, as well as the HEPES buffer solution, were purchased from Atlanta 
Biologicals (Lawrenceville, GA).  Dexamethasone, nicotinamide, ascorbic acid 
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diphosphate, DMSO, and insulin solution were acquired from Sigma (St. Louis, MO).  
Human HGF and mouse OSM were purchased from R&D Systems (Minneapolis, 
MN).  Pharm Lyse solution was from BD Pharmingen (San Jose, CA).  Collagen stock 
solution was purchased from Angiotech BioMaterials (Palo Alto, CA).  Tissue-culture 
treated polystyrene plates, cell strainers, and collagen-coated chamber slides were 
obtained from BD Discovery Labware (San Jose, CA).  Beta-mercaptoethanol, Tris-
HCl, EDTA, and Triton-X100 stock solutions were from American Bioanalytical 
(Natick, MA).  Paraformaldehyde stock solution was acquired from Electron 
Microscopy Sciences (Hatfield, PA).  The MTS assay was performed using a 
commercially available kit from Promega (Madison, WI).  PicoGreen dsDNA 
Quantitation kit was acquired from Molecular Probes (Eugene, OR).  Albumin ELISA 
kit was purchased from Bethyl Laboratories (Montgomery, TX). 
 
2.2.2  Isolation and processing of fetal liver cells  
Methods for the isolation and processing of fetal liver cells were modified 
from previously reported protocols 
2, 10.  Timed pregnancies were set up using C57Bl/6 
mice.  Noon of the day a vaginal plug was found was considered as 0.5 embryonic day 
(E0.5).  On E14.5, fetuses were retrieved from the pregnant mice.  Each pregnant 
mouse yielded 5 – 12 fetuses.  Fetal livers were aseptically dissected from the fetuses 
under dissection microscope and maintained in DPBS + 1% antibiotic-antimycotic on 
ice until use.  To extract fetal liver cells, fetal livers were treated with 0.1% trypsin for 
10 minutes at 37ºC.  Subsequently, the livers were triturated with P1000 pipettes to 
achieve a single cell suspension, and 10% FBS-containing medium was added to 
neutralize the trypsin.  The cells were pelleted and resuspended in Pharm Lyse 
solution to lyse erythrocytes.  After 10 minutes of incubation in the dark at room 
temperature (RT), 10% FBS-containing medium was added to dilute the Pharm Lyse.  
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The cells were pelleted at 1,100 rpm for 5 minutes, resuspended in the same medium, 
and re-pelleted at 1,100 rpm for 5 minutes.  The cell pellet was resuspended in 1 ml of 
culture medium, and filtered with a cell strainer (40 µm pore size).  Another ml of 
medium was used to rinse the filter and combined with the cell suspension.  In 
average, this process yields 1.07X10
8 fetal liver cells from each pregnant mouse (n = 
11). 
 
2.2.3  Culture of fetal liver cells 
The compositions of the culture media studied in this chapter are described in 
Table 2.1.  Incomplete culture media, which were used for the first day of culture, 
refer to media that were not supplemented with insulin, EGF, HGF, OSM, or DMSO.  
Complete culture media included all those factors and were used for the rest of the 
culture period. 
On day 0 (day of culture set-up), collagen working solution was prepared by 
diluting the stock (2.9 mg/ml) 1:10 with sterile water.  Twelve-well tissue-culture 
treated polystyrene plates were coated with the collagen working solution at 37ºC for 
1 hour, and rinsed with sterile water.  The wells were then stored in DPBS until use. 
The processed fetal liver cells were counted by Trypan Blue exclusion, and 
diluted with the incomplete culture medium of interest to 2X10
5 cells/ml.  This 
suspension was plated onto the collagen-coated plates at 1 ml/well, resulting in a 
plating density of 5X10
4 cells/cm
2.  After 20 – 24 hours of culture, culture supernatant 
was removed and the culture wells were rinsed with DPBS to remove non-adherent 
cells.  Complete culture medium was then added at 1 ml/well.  Culture medium was 
changed every 2 – 3 days thereafter. 
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Table 2.1  Formulations of the culture media studied in this chapter. 






















5 mM -  5 mM
Dexamethasone 
 
0.1 µM 1 µM  1 µM
Nicotinamide 
 
10 mM 10 mM  10 mM
Ascorbic acid diphosphate 
 
- 0.5 mM  0.5 mM







1 µg/ml  1 µg/ml
EGF 
 
20 ng/ml 10 ng/ml  20 ng/ml
HGF 
 
50 ng/ml -  50 ng/ml
OSM 
 
- 10 ng/ml  10 ng/ml
DMSO 
 
-1 %  1 %
 
 
                                                 
1  Contains 10,000 U/ml of penicillin (base), 10,000 µg/ml of streptomycin (base), and 25 µg/ml of 
amphotericin B in 0.85% saline (information provided by the product manufacturer). 
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2.2.4  Assessment of cell growth 
Cell growth was monitored by MTS assay and DNA assay. The MTS assay 
measures the conversion of a tetrazolium compound into aqueous, soluble formazan 
by dehydrogenase enzymes found in metabolically active cells.  In addition, the total 
amount of DNA extracted from each culture well was quantified with the PicoGreen 
dsDNA Quantitation kit. 
The culture medium used for the MTS assay consisted of phenol-red-free 
DMEM/F12 + 10% FBS + 1% L-glutamine + 1% non-essential amino acids + 1% 
antibiotic-antimycotic.  To perform the MTS assay, culture media were removed and 
the wells were rinsed with DPBS to remove residual media with phenol red.  
Subsequently, 1 ml of MTS medium was added to each well.  This was followed by 
the addition of 200 µl/well of PMS/MTS mixture, which was pre-mixed and frozen in 
aliquots at –20ºC according to the manufacturer’s instructions.  The plate was placed 
in a cell culture incubator for 2 hours.  Afterwards, 120 µl of suspension (in triplicate) 
from each culture well was transferred to a 96-well plate.  Optical absorbance was 
measured in dual mode (at 490 nm with a reference at 630 nm) with an ELx808 
microplate reader (BIO-TEK Instruments, Winooski, VT).  On day 0, MTS assay was 
performed on a serial titration of the processed fetal liver cells (8X10
6 – 7.8X10
3 
cells/well at 1:2 titration) to test the linearity of the assay. 
Following the MTS assay, the supernatant was aspirated from the culture 
wells, which were then rinsed with DPBS.  Subsequently, the cells were detached by 
incubation with Trypsin/EDTA at 37ºC for 10 minutes.  The cells were pelleted, 
resuspended in 200 µl of DPBS, and stored at –80ºC until use.  To extract DNA, these 
samples were thawed, brought to RT, and mixed with 200 – 400 µl of lysis solution 
(10 mM Tris-HCl + 1 mM EDTA + 0.2% Triton-X100, pH 7.5).  The cell suspension 
was sonicated on ice for 1 minute using a sonicator (VibraCell model, Sonics & 
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Materials, Newton, CT) with an output level of 4 and a 40% duty cycle.  The sonicated 
samples were stored at –80ºC until use.  On the day of DNA analysis, the sonicated 
samples were thawed and quantified for DNA according to the PicoGreen kit 
manufacturer’s instruction.  Fluorescence was measured with a CytoFluor 2350 
fluorimeter (Millipore, Billerica, MA).  Standard curves using serially diluted day 0 
fetal liver cells (8X10
6 – 7.8X10
3 cells at 1:2 titration) were used to test the linear 
ranges of the assay at various sample dilutions. 
 
2.2.5  Analysis of hepatocyte functions 
Albumin synthesis and glycogen accumulation were analyzed to evaluate the 
development of hepatocyte functions in the fetal liver cell cultures. 
At each medium change, spent culture medium from each well was collected 
and centrifuged to pellet non-adherent cells and debris.  The top 80-90% of the spun 
medium was collected and stored at –80ºC until analysis.  Mouse albumin secreted 
into the culture media was measured by ELISA assay according to the kit 
manufacturer’s instructions.  Optical absorbance was measured at 490 nm on the same 
plate reader as the MTS assay.  The culture media alone did not give any positive 
reading, indicating that cross-reactions between the ELISA antibody and the FBS 
contained in the media were negligible. 
Periodic acid-Schiff (PAS) staining of the cultures was performed to assess 
glycogen accumulation.  Cultures for PAS staining were set up in collagen-coated 
chamber slides in parallel with those in 12-well plates on day 0.  The number of cells 
seeded into the chamber wells was scaled according to available culture surface to 
maintain the plating density at 5X10
4 cells/cm
2.  At designated time points, spent 
culture media was aspirated.  The chamber wells were quickly rinsed with DPBS, and 
fixed with 4% paraformaldehyde at RT for 10 minutes.  The fixed wells were rinsed 
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twice with DPBS, at RT for 5 minutes each.  The rinsed wells were air dried for at 
least 1 hour before being sealed and stored at –80ºC.  For staining, the chamber wells 
were brought to RT, air dried, and submitted to Research Histology at Yale University 
for PAS staining. 
 
2.2.6 Statistics 
All experiments were performed at least 3 times using cells from different 
animals, with each condition tested in 2 - 6 replicates.  Similar trends were observed in 
all experiments.  Student’s t-test was used to evaluate the statistical significance where 





2.3.1  Fetal liver cells cultured in media E and WD 
This set of experiments compared the culture of E14.5 mouse fetal liver cells 
in two representative medium formulations based on HGF/EGF and OSM/DMSO as 
the key regulating factors, respectively, as well as a two-step approach in which the 
two media were applied sequentially.  The fetal liver cells were cultured: 1) for 2 
weeks in the HGF/EGF-containing medium (medium E); 2) for 2 weeks in the 
OSM/DMSO based medium (medium WD); 3) in medium E for 1 week followed by 
another week in medium WD (medium EWD). 
 
Morphological changes 
After the removal of non-adherent cells (predominantly blood cells) at day 1, 
only about 5% of the seeded cells remained in the culture wells.  The attached cells 
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included mostly nonparenchymal cells and a few clusters of cells with very small cell 
size (5 – 10 µm).  In medium E and medium WD, these small cells increased in 
number over time, and became drastically different in morphology starting around day 
4 - 5. 
As reported, medium WD induced a cell morphology resembling that of more 
differentiated hepatocytes.  Starting around day 3 - 4, the small cells in the culture 
gradually enlarged in size, reaching 20 –40 µm at day 15, and exhibited the polyhedral 
shape that is typical of differentiated hepatocytes.  These cells also possessed spherical 
nuclei with one or more prominent nucleoli, another signature of hepatocytes.  Over 
time, a portion of the cells became binucleate, similar to what is observed in adult liver 
(Figure 2.1).  Compared with the WD cultures, the small cells in medium E appeared 
to proliferate much faster.  However, throughout the 2-week culture period, they 
remained as tightly packed, round, and small cells, often with high nucleus to 
cytoplasm ratio.  Few differentiated hepatocytes were observed.  When the culture 
medium was switched to WD (EWD), cells originally cultured in medium E started to 
display hepatocyte morphology within 2 days: they increased in cell size, became 
polygonal, and the number of binucleate cells increased over time. 
 
Cell growth 
Consistent with visual inspection, results from DNA assay and MTS assay 
indicated that cells cultured in medium E initially underwent rapid expansion (Figure 
2.2).  At day 7, total cellular DNA increased by 219.3 fold compared with day 1.  
However, the growth declined after this period, as reflected by a much slower increase 
in the total DNA and a decrease in the MTS activity after 1 week.  On the other hand, 
the DNA content and MTS activity of cells cultured in medium WD increased slowly  
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Figure 2.1  Morphology of E14.5 mouse fetal liver cells cultured for 2 weeks in 
medium WD; for 2 weeks in medium E; or for 1 week in medium E followed by 






































































Figure 2.2  Proliferation of E14.5 mouse fetal liver cells as measured by DNA assay 
(A) and MTS assay (B) when cultured in medium E, WD, and EWD. 
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but steadily over time, and eventually caught up with those in medium E.  By 
switching the medium from E to WD at day 7, the decline of cell growth observed in E 
cultures was somewhat ameliorated: the total DNA increased at a higher rate, reaching 
a level 20% and 37% higher than those in medium E and WD, respectively, at the end 
of the culture.  However, the switch did not restore the MTS activity: it decreased 
during the first 2 days of the switch before recovering to a level similar to those in 
medium E and WD. 
 
Albumin synthesis 
The level of albumin synthesis in medium E was much higher than that in 
medium WD for a large part of the experiment (the first 10 – 11 days, Figure 2.3).  
The total secretion rate and specific secretion rate in medium E climbed rapidly during 
the first week, reaching to 8.4 and 6.4 fold of those in medium WD, respectively, on 
day 8.  However, the synthesis decreased steadily thereafter, eventually to a level 
similar to that in medium WD around day 12.  When switching from medium E to 
medium WD at day 7, albumin secretion dropped even more significantly and only 
recovered to the level of media E and WD at the end of the experiment. 
 
Glycogen accumulation 
The ability of the cultured cells to produce and store glycogen was also 
examined under the three conditions.  After one week of culture, many cells in 
medium WD showed an intense staining that indicates high level of glycogen 
accumulation (Figure 2.4).  All of these stained cells had the appearance of more 
differentiated hepatocytes.  The staining pattern of the WD cultures remained similar 
till the end of the 2-week culture.  In contrast, only a small percentage of the cells in 
medium E were stained after 1 week.  The stained cells also displayed the 
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Figure 2.3  Albumin secretion of E14.5 mouse fetal liver cells cultured in medium E, 
WD, and EWD, as indicated by the total secretion rate (µg albumin/well-day, A) and 
the specific secretion rate (µg albumin/µg DNA-day, B). 
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Figure 2.4  Glycogenesis of E14.5 mouse fetal liver cells cultured in medium WD for 
1 week (A) or 2 weeks (B), in medium E for 1 week (D) or 2 weeks (E), and in EWD 
for 2 weeks (F).  The stained cells in all three cultures displayed the morphology of 
mature hepatocytes (C).  Magnification = 4X (A - B, D - F) or 40X (C).  Scale bar = 
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differentiated hepatocyte morphology.  However, only a very low level of staining 
remained in the E cultures after 2 weeks.  By switching the medium from E to WD at 
day 7, many intensely stained cells were observed at day 15, all of which exhibited the 
typical hepatocyte morphology. 
 
2.3.2  A Modified medium condition for fetal liver cell culture 
Based on the results in section 2.3.1, experiments in this section investigated 
whether the growth and differentiation of fetal liver cells could be further improved by 
modulating the regulatory factors and the timing of their addition.  E14.5 mouse fetal 
liver cells were cultured: 1) for 2 weeks in medium E; 2) for 2 weeks in a modified 
medium supplemented with HGF, EGF, OSM, and DMSO (medium DD); 3) in 
medium E for 1 week followed by another week in medium DD. 
 
Morphological changes 
The morphology of the E cultures was similar to what was described in section 
2.3.1 (Figure 2.5).  In DD medium, clusters of small hepatocytes started to emerge 
around day 4 – 5.  Similar to the WD cultures, these cells enlarged in size and acquired 
the morphology of mature hepatocytes over time.  Yet unlike those in medium WD, 
cells cultured in medium DD demonstrated a higher expansion capacity.  Similar to 
the EWD cultures, cells originally cultured in medium E started to display hepatocyte 
morphology within 2 days of switching to medium DD. 
 
Cell growth 
Similar to what was previously observed, cell proliferation in medium E was 
rapid initially but stalled after one week, as indicated by a plateau in the DNA content 
after day 5 and a decline in MTS activity after day 7 (Figure 2.6).  In contrast, the 
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Figure 2.5  Morphology of E14.5 mouse fetal liver cells cultured for 2 weeks in 
medium DD, for 2 weeks in medium E, or for 1 week in medium E followed by 








































































Figure 2.6  Proliferation of E14.5 mouse fetal liver cells as measured by DNA assay 
(A) and MTS assay (B) when cultured in medium E, DD, and EDD. 
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DNA content and MTS activity of the DD cultures increased at a rate similar to those 
in medium E during the first 5 days but continued to rise thereafter, albeit at a slower 
rate.  Similar to the switch from medium E to medium WD, changing the medium 
from E to DD at day 7 prolonged the increase of DNA content.  Unlike the EWD 
condition, this switch did not cause a drop in MTS activity and restored it to a level 
significantly higher than that of the E cultures (p < 0.05 for day 11, 13, 15).  The DD 
and EDD conditions both led to significantly higher cell expansion (measured by the 
increase in total cellular DNA) compared with medium E: at the end of a 15-day 
culture, cell expansion in DD and EDD cultures were 2.3 and 1.6 fold higher than that 
in medium E, respectively (p < 0.05). 
 
Albumin synthesis 
Albumin synthesis in medium E followed a trend similar to what was 
described in 2.3.1: it increased rapidly during the first week but declined thereafter 
(Figure 2.7).  In contrast to the EWD condition, switching the E cultures to medium 
DD at day 7, when albumin secretion was at its peak, stabilized the secretion at this 
level.  Interestingly, although albumin secretion in medium DD was low initially, it 
increased with time in an almost linear fashion and eventually surpassed the secretion 
level in EDD.  At the end of a 15-day culture, the total secretion rate and specific 
secretion rate in medium DD were 1.9 and 1.6 times higher than those in EDD, 
respectively (p < 0.05). 
 
Glycogen accumulation 
Glycogenesis of the three cultures is demonstrated in Figure 2.8.  As described 
before, the cultures in medium E contained only a few intensely stained hepatocytes at 
day 7 and the staining was largely diminished at day 15.  This was overcome by  


























































































































Figure 2.7  Albumin secretion of E14.5 mouse fetal liver cells cultured in medium E, 
DD, and EDD, as indicated by the total secretion rate (µg albumin/well-day, A) and 
the specific secretion rate (µg albumin/µg DNA-day, B). 
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Figure 2.8  Glycogenesis of E14.5 mouse fetal liver cells cultured in medium DD for 1 
week (A) or 2 weeks (B), in medium E for 1 week (C) or 2 weeks (D)
2, and in EDD 
for 2 weeks (E).  After 2 weeks of culture in medium DD or EDD, both intensely 
stained mature hepatocytes (F) and intermediately stained small cells (G) were 
observed.  Magnification = 4X (A - E) or 40X (F - G).  Scale bar = 500 µm (A – E) or 
100 µm (F – G). 
 
 
                                                 
2  Figure 2.8C is the same as Figure 2.4D; Figure 2.8D is the same as Figure 2.4E. 
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switching the medium to DD at day 7: a large number of intensely stained hepatocytes 
were observed at day 15.  The staining of DD cultures was unremarkable at day 7.  
However, by day 15, the staining level in DD was the highest among all culture 
conditions (including WD and EWD).  Interestingly, the staining was contributed by 
two groups of cells with distinct morphologies: large hepatocytes with intense 
staining, and intermediately stained clusters of tightly packed small cells that did not 
resemble differentiated hepatocytes.  The latter was also observed in the EDD 
cultures, but the number of clusters was lower than in DD. 
 
Overall comparison 
When all the culture conditions were compared together, cell growth and 
albumin secretion appeared to be the highest in medium DD.  In average, cell 
expansion (measured by the fold of increase in cellular DNA) in medium DD was 
about 2 fold of that under other conditions.  At the end of a 2-week culture, the total 
albumin secretion rate and the specific albumin secretion rate in medium DD were 2 - 





2.4.1  Rationale and summary of results 
The purpose of this study was to establish a medium condition that promotes 
optimal growth and hepatic differentiation of mouse fetal liver cells.  The study began 
with a comparison of media E, WD, and EWD, respectively representing published 
methods that support growth, hepatocyte differentiation, or both growth and 
differentiation (results summarized in Table 2.2).  The outcome of the experiments 
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was unexpected.  Rapid cell proliferation and albumin synthesis were promoted in 
medium E but could not be sustained beyond one week of culture (Figure 2.2 and 
Figure 2.3).  Furthermore, albumin secretion in medium WD was much lower than in 
medium E for most of the culture period (Figure 2.3), suggesting that the WD cultures 
either synthesized less albumin on a per-cell base or contained a lower percentage of 
albumin-secreting cells.  This was especially surprising because only a few cells in 
medium E possessed the mature hepatocyte morphology and glycogen storage ability 
that were prevalent in cultures maintained in medium WD (Figure 2.1 and Figure 2.4).  
Finally, compared with E and WD, the two-step approach (EWD) prolonged the 
increase of cellular DNA (Figure 2.2), induced morphological maturation (Figure 2.1) 
and glycogenesis (Figure 2.4), but could not restore albumin secretion (Figure 2.3).  
These results suggested that, with regard to their intended usage, the tested methods 
are not as effective as previously reported 
2, 3, 10. 
 
Table 2.2  Summary of the comparison of media E, WD, and EWD. 
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3  “Week” is abbreviated as “Wk”. 
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Since the outcome of the above experiment was less than satisfying, the second 
part of the study investigated whether the growth and differentiation of fetal liver cells 
could be enhanced by modulating the regulatory factors and the timing of their 
supplementation (results summarized in Table 2.3).  A modified medium, DD, was 
designed based on E and WD to contain both growth- and differentiation-stimulating 
factors.  Replacing WD with this medium in the two-step approach stabilized albumin 
secretion at the peak level achieved in medium E (Figure 2.7).  When used alone, 
medium DD led to the highest cell expansion among all conditions and was able to 
sustain the growth for 2 weeks (Figure 2.6).  Hepatic differentiation, demonstrated by 
morphological maturation (Figure 2.5) and glycogenesis (Figure 2.8), was also readily 
induced.  Furthermore, albumin secretion in medium DD increased continuously over 
time, and became significantly higher than in all other cultures (Figure 2.7).  These 
results are consistent with previous findings that the combination of HGF and OSM 
enhances the growth and hepatic differentiation of putative hepatic progenitors 
18. 
 
Table 2.3  Summary of the comparison of media E, DD, and EDD. 
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4  “Hepatocytes” is abbreviated as “hep”. 
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2.4.2  Effects of regulatory signals and timing of their addition 
Suzuki et al. previously reported that HGF plays multiple roles in the 
development of liver stem cells isolated from E13.5 livers (Figure 2.9) 
19.  First, HGF 
directly mediates the early transition of albumin-negative (ALB
-) stem cells to 
bipotential, transitory albumin-positive (ALB
+) hepatic precursors that resemble 
hepatoblasts.  Second, it encourages the bipotential ALB
+ precursors to become 
committed ALB
+ hepatocyte precursors.  Last, HGF functions as a potent mitogen for 
both ALB
- stem cells and differentiating ALB
+ precursors.  On the other hand, OSM 
inhibits the proliferation of ALB
- stem cells and has no mitogenic effect on ALB
+ 
precursors.  However, OSM, but not HGF, induces the ALB
+ precursors to further 
differentiate into mature hepatocytes. 
These findings could help to understand the complex growth and 
differentiation dynamics observed in this study.  The fetal liver cells used for this 
study were not further fractioned, and thus contained both ALB
- stem cells and ALB
+ 
precursors.  In medium E, HGF converted the ALB
- stem cells to ALB
+ precursors and 
strongly stimulated their proliferation, resulting in the initial rapid increase in DNA 
content, MTS activity, and albumin secretion.  However, the maturation process was 
halted in the absence of OSM.  This was demonstrated by the lack of morphological 
maturation, as well as a very low level of glycogenesis that was likely to be induced 
by dexamethasone 
8.  In medium WD, OSM efficiently induced the maturation of the 
ALB
+ hepatocyte precursors existing in the starting population, giving rise to 
glycogenic cells with mature hepatocyte morphology.  Yet, in absence of HGF, the 
number of these cells increased slowly due to low mitogenic stimulation and a lack of 
new ALB
+ precursors generated from ALB
- stem cells.  Hence, the PAS staining 
pattern remained similar over time.  The albumin secretion rates, which evaluate the 
average secretion level of the whole culture, also remained low. 











Figure 2.9.  Proposed mechanism of hepatic stem cell proliferation and differentiation 
regulated by HGF and OSM 
19.  Black horizontal arrows indicate the direction of 
differentiation, while black arc-shaped arrows symbolize self-renewal or proliferation.  
Red and blue arrows represent up-regulation and down-regulation, respectively.  The 















  Medium DD is essentially medium E supplemented with ascorbic acid, OSM, 
DMSO, and more dexamethasone, all of which are present at the same concentrations 
in medium WD as well (Table 2.1).  Therefore, it is not surprising that both of the 
two-step approaches, EWD and EDD, induced maturation of the ALB
+ precursors 
generated and expanded in medium E.  However, switching from medium E to WD 
caused noticeable setbacks in MTS activity and albumin secretion, which were not 
observed with EDD.  One possible reason could be that E and DD share the same 
basal medium DMEM/F12, the composition of which differs from the Williams’ E 
that WD is based on.  Consequently, an adaptation phase was required with the E-to-
WD switch but not with EDD.  This hypothesis is supported by a previous study on 
fetal liver cell culture, in which switching from αMEM to Willams’ E medium either 
led to reduced cell number or could not restore albumin secretion 
16.  Therefore, two-
step approaches combining basal media with rather different compositions may not be 
optimal.  Second, HGF contained in medium DD stimulated the continual proliferation 
and differentiation of ALB
+ precursors, and thus helped to stabilize the levels of 
albumin secretion and MTS activity.  The effect of HGF was further reflected in the 
PAS staining pattern of EDD cultures: besides the intensely stained mature 
hepatocytes that were also observed in WD and EWD, there existed intermediately 
stained small cells that were possibly newly generated, not fully differentiated 
hepatocytes.  Therefore, the presence of HGF even in the so-called “maturation phase” 
could be beneficial. 
When medium DD was used alone, the growth and maturation stimulators in 
the medium formed an “assembling line”: committed hepatic precursors were 
constantly generated owing to HGF, which induced the proliferation and early 
differentiation of ALB
- stem cells and ALB
+ precursors.  Subsequently, the hepatic 
precursors matured into hepatocytes under the stimulation of OSM.  The concerted 
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actions of HGF and OSM resulted in an apparent association of growth and 
differentiation, as reflected by the simultaneous increases in DNA content and 
albumin secretion throughout the culture period.  Additionally, similar to EDD, both 
intensely stained hepatocytes and intermediately stained small cells were observed in 
PAS staining. 
Compared with EDD, cell growth, albumin synthesis, and glycogenesis were 
further enhanced when medium DD was used throughout the culture period.  The 
improvements may be due to the presence of ascorbic acid, which is known to protect 
both adult and fetal hepatocytes against apoptosis 
20, 21.  It is possible that, in medium 
E, the ALB
- stem cells and ALB
+ precursors were lost over time in the absence of the 
protective agents, as demonstrated by the decline of cell growth and albumin secretion 
after their initial ascent.  Hence, EDD cultures were likely to contain less stem cells 
and precursors than cultures maintained in medium DD alone, in which the cells were 
protected from the very beginning.  Consequently, after the medium switch, albumin 
secretion increased at a much slower rate in EDD than in DD.  This is further 
illustrated by the pattern of PAS staining, wherein more extensive staining and more 
intermediately stained small cells were observed in DD than in EDD.  Therefore, 
supplying protective reagents from the very beginning could augment cell growth and 
hepatic differentiation. 
In summary, results from this study show that the growth and differentiation 
kinetics of fetal liver cells are influenced not only by the regulatory factors that are 
present, but also by the timing of their addition.  HGF is required through out the 
culture to induce the differentiation of ALB
- stem cells into hepatic precursors and to 
ensure the continual proliferation of stem cells and precursors.  The constant presence 
of protective agents such as ascorbic acid helps to enhance cell survival, resulting in 
improved cell expansion and hepatocyte functions.  Finally, timing of the addition of 
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maturation factors such as OSM determines the kinetics of cell differentiation.  In the 
presence of HGF, addition of OSM from the very beginning results in concurrent 
growth and differentiation. 
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Three-dimensional (3D) scaffolds play a central role in liver tissue  
engineering 
1-3.  Compared with two-dimensional (2D) culture surfaces, these 
scaffolds have a large surface area-to-volume ratio that potentially allows the growth 
of a large cell mass that is required for clinical efficacy.  They also provide a 3D space 
for potential tissue formation and offer temporary mechanical support during this 
process.  Furthermore, the scaffold serves as a delivery system that enables the 
transplantation of organized cells/tissues rather than single cells. 
Scaffolds constructed from both synthetic and natural materials have been 
studied for liver tissue engineering.  Among the synthetic materials, poly(lactic acid) 
(PLA), poly(glycolic acid) (PGA), and their copolymer poly(lactic-co-glycolic acid) 
(PLGA) have been studied extensively 
4-13.  These polymers are biodegradable, 
biocompatible, and have been approved by the Food and Drug Administration (FDA) 
for applications such as wound dressings and surgical sutures 
2.  The polymers are 
fabricated into highly porous structures that can house a large number of hepatocytes, 
facilitate the transport of oxygen, nutrients and metabolic wastes, and allow vascular 
in-growth.  Concomitant with the increase in cell mass, the scaffold degrades via 
hydrolytic cleavage of the ester bonds, leaving only the naturally generated tissue 
consisting of the transplanted cells and the in-grown host tissues. 
Alternatively, biopolymers such as collagens, alginate, hyaluronate, and fibrin 
have been studied as scaffold materials for hepatocyte culture and transplantation 
14-18.  
Among them, type I and type IV collagens have been shown to enhance the adhesion 
56   57
and long-term survival of adult hepatocytes in vitro 
19-21.  Consequently, they have 
been extensively applied as hepatocyte growth substrates, in the form of thin coating, 
soft gel, or 3D matrix 
14, 22-24.  It has also been reported that type I and type IV 
collagens enhance the proliferation and differentiation of liver stem cells and hepatic 
progenitors 
25. 
A more complex form of natural scaffold, decellularized liver biomatrix, has 
also been explored.  Typically, the liver tissues are subjected to a series of chemical 
treatment to remove the cellular components, resulting in scaffolds constituted by 
liver-specific extracellular matrix (ECM).  Rojkind and colleagues first introduced this 
technique to isolate connective tissue fibers from the liver 
26.  When coated onto tissue 
culture dishes, the biomatrix was able to improve the long-term survival and metabolic 
functions of adult hepatocytes 
26, 27.  A recent study suggested that the decellularized 
liver matrix could also be employed as a scaffold for long-term hepatocyte culture 
28. 
Compared to their synthetic counterparts, scaffolds constructed from ECM 
components are more conducive to cell attachment and biological recognitions.  By 
preserving the intact ECM of a tissue, a decellularized matrix may offer an even more 
“native” microenvironment as well as a growth template that captures the architecture 
of the tissue 
29.  However, clinical application of these scaffolds is limited by batch-to-
batch variation and scale-up problem in mass production 
28.  On the other hand, the 
synthetic scaffolds can be produced in large quantity with good reproducibility.  They 
also offer much more design flexibility: the physical, chemical, mechanical, and 
degradation properties of the scaffolds can be precisely controlled and tailored for 
specific applications 
30, 31.  Furthermore, cell-adhesion peptides and growth factors can 
be incorporated into the synthetic scaffolds to provide both spatial and temporal cues 
to guide tissue formation 
32, 33. 
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Although adult hepatocyte/scaffold composites have been extensively studied 
for the past several decades, limited information is available regarding the cultivation 
of fetal liver cells on 3D scaffolds.  Moreover, while the previous studies customized 
the culture medium for fetal liver cells, they all used scaffold materials originally 
designed for adult hepatocyte cultures 
34-38. 
This study was intended as a general survey of the currently available scaffolds 
regarding their effectiveness in supporting the growth and differentiation of fetal liver 
cells.  Three representative scaffolds, decellularized liver matrix, collagen scaffold 
prepared from type I and IV collagens, and PLGA scaffold, were compared.  The 
objective was to obtain information on scaffold properties that are possibly crucial to 
the development of fetal liver cells.  First, decellularized liver matrices were produced 
and characterized.  The three types of scaffolds were then used for fetal liver cell 
culture and were evaluated for their impact on cell behaviors including cell 
distribution, cell growth, and differentiation. 
 
 
3.2  MATERIALS AND METHODS 
 
3.2.1 Materials 
PLGA (50:50, Mw ~ 84,000) was purchased from Birmingham Polymers 
(Pelham, AL).  Chloroform was from J.T. Baker (Phillipsburg, NJ).  Sodium chloride 
(NaCl), sodium dodecyl sulfate (SDS), and osmium tetroxide were purchased from 
Sigma (St. Louis, MO).  Formalin (10%, neutral, phosphate buffer) and glutaraldehyde 
were acquired from Polysciences (Warrington, PA).  Sodium cacodylate buffer was 
from Electron Microscopy Sciences (Hatfield, PA).  Heparine and saline were from 
Abbott Laboratories (North Chicago, IL).  Ketamine was from Fort Dodge Animal 
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Health (Fort Dodge, IA) and xylazine was from Ben Venue Laboratories (Bedford, 
OH).  Teflon vials were purchased from Cole Palmer (Vernon Hills, IL).  Three-
dimensional collagen matrices and nontreated 12-well plates were from BD Discovery 
Labware (San Jose, CA).  The rest of the materials were obtained from the same 
sources as described in chapter 2 (section 2.2). 
 
3.2.2  Preparation of PLGA scaffolds 
PLGA scaffolds were prepared with a salt leaching technique.  PLGA was 
dissolved in chloroform overnight to prepare a 5% (w/v) solution.  Subsequently, 0.24 
ml of this solution was added into a Teflon vial packed with 0.6 g of NaCl particles 
that were sieved to a size of 125 – 250 µm.  The vials were capped, tapped gently, and 
allowed to sit for 30 minutes to ensure the salt was level in the polymer solution.  The 
vials were then uncapped in the fume hood to allow the solvent to evaporate overnight.  
The resulting polymer-salt composites were removed from the vials, placed in tissue 
cassettes, and immersed in deionized water.  The salt was leached out through at least 
6 hourly water changes.  The scaffolds were then removed from the cassettes, blotted 
dry, and lyophilized for 2 - 3 days.  The scaffolds were stored in sealed containers 
with desiccant at –20ºC until use. 
 
3.2.3  Decellularization of livers 
Liver decellularization was performed on C57Bl/6 mice or Sprague-Dawley 
rats (Jackson Laboratory, Bar Harbor, Maine).  The animals were anesthetized by 
intraperitoneal injection of 100/10 mg/kg body weight of ketamine/xylazine solution, 
respectively.  Subsequently, the animal was perfused at 10 ml/min with saline that 
contained 1 unit/ml of Heparin using a Rabbit-Plus peristaltic pump (Rainin 
Instrument, Woburn, MA).  The perfusion fluid was directed into the left ventricle and 
   60
drained through the hepatic vein.  The animal was perfused until most of the blood 
was removed from the liver.  The perfused liver was dissected out, and cut into pieces 
of ~ 10 X 10 X 5 mm
3.  The tissue chunks were incubated in sterile 1% Triton-X100 
solution in a rotating shaker at 150 rpm at 37ºC.  After 24 hours, the solution was 
switched to sterile 1% SDS and the incubation was continued.  The SDS solution was 
changed every 2 – 3 days until the tissues became white and transparent, which took   
1 – 2 weeks.  Subsequently, the incubation was continued with sterile water to rinse 
the tissues.  The water was changed every 2 - 3 days for at least 4 times.  The 
decellularized tissues were then stored at 4ºC in sterile DPBS with 1% antibiotic-
antimycotic until use. 
 
3.2.4  Culture of fetal liver cells on matrices 
The matrices were prepared for cell attachment before culture set-up.  The 
PLGA scaffolds were soaked in 70% ethanol overnight for pre-wetting and 
sterilization.  On day 0, collagen working solution was prepared by diluting the stock 
(2.9 mg/ml) 1:10 with sterile water.  The ethanol-treated polymer scaffolds were 
rinsed twice with DPBS, coated with the collagen working solution at 37ºC for 1 hour, 
and rinsed with sterile water.  The coated scaffolds were stored in DPBS until use.  
Decellularized tissues and collagen matrices were immersed in 10% FBS-containing 
culture medium overnight at 4ºC before use. 
The isolation and processing of fetal liver cells were performed as described in 
Chapter 2 (section 2.2.2).  The processed fetal liver cells were resuspended in 
incomplete DD culture medium at a concentration of 5X10
6 cells/ml or 1X10
7 
cells/ml.  Each matrix was placed in a well of a nontreated 12-well plate, and the cell 
suspension was added carefully in a drop-wise fashion onto each matrix.  Two 
hundred microliters of the 5X10
6 cells/ml cell suspension was used to seed each 
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PLGA scaffold.  Due to their smaller sizes, collagen matrices and decellularirzed liver 
tissues were seeded with 100 µl of the 1X10
7 cells/ml cell suspension.  The matrices 
were then placed in a cell culture incubator for 3 hours to allow cell attachment.  
Afterwards, incomplete DD culture medium was carefully added to each well.  After 
20 – 24 hours of culture, the culture supernatant was removed and the matrices were 
rinsed with DPBS to remove non-adherent cells.  The rinsed matrices were transferred 
into a new nontreated 12-well plate, and cultured with complete DD medium.  Culture 
medium was changed every 2 – 3 days thereafter. 
 
3.2.5  Assessment of cell growth 
Cell growth on the matrices was monitored by MTS assay and DNA assay.  To 
perform MTS assay, culture medium was removed and the matrices were rinsed with 
DPBS to remove residual medium with phenol red.  The matrices were then 
transferred to a new 12-well plate to exclude cells growing off the matrices.  The MTS 
assay was then performed as described in Chapter 2 (section 2.2.4).  Again, MTS 
assay was performed on day 0 on a serial titration of the processed fetal liver cells 
(8X10
6 – 7.8X10
3 cells/well at 1:2 titration) to test the linearity of the assay. 
Following the MTS assay, the supernatant was aspirated from the culture 
wells, which were then rinsed with DPBS.  Each matrix was then transferred to an 
Eppendorf tube containing 200 µl of DPBS, and stored at –80ºC until use.  To extract 
DNA, the samples were thawed, mixed with 200 – 400 µl of lysis solution, and cut 
into fine pieces with clean scissors.  The samples were sonicated as described in 
section 2.2.4, and stored at -80ºC until use.  Before DNA assay, the sonicated samples 
were thawed and centrifuged in a microcentrifuge at 14,000 rpm at 4ºC for 30 minutes 
to spin down all debris.  The supernatant was transferred to a new tube and quantified 
for DNA as described in section 2.2.4.  Standard curves using serially diluted day 0 
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fetal liver cells (8X10
6 – 7.8X10
3 cells at 1:2 titration) were used to test the linear 
ranges of the assay at various sample dilutions. 
 
3.2.6  Analysis of hepatocyte functions 
Albumin secretion was analyzed as described in Chapter 2 (section 2.2.5). 
 
3.2.7  Histology and PAS staining 
Decellularized tissues and cell-seeded matrices were rinsed with DPBS, and 
fixed with 10% neutral formalin at RT for 4 hours.  The fixed samples were 
transferred into 70% ethanol and submitted to Research Histology at Yale University 
for paraffin embedding.  Hematoxylin-Eosin (H&E) and PAS stainings were 
performed by Research Histology on 5 µm thick paraffin sections. 
 
3.2.8  Scanning electron microscopy (SEM) 
Decellularized tissues and cell-seeded scaffolds were fixed, dehydrated, and 
dried before SEM examination.  Briefly, the samples were rinsed with 0.1 M sodium 
cacodylate buffer, and fixed with 2.5% glutaraldehyde (in 0.1M sodium cacodylate 
buffer) overnight.  The fixed samples were rinsed 3 times with the cacodylate buffer: 
the first and last rinses at RT on a shaker for 15 minutes, the second one at 4ºC for 
overnight.  The samples were post-fixed in 1% osmium tetroxide (in 0.1M sodium 
cacodylate buffer) at 4ºC for 1 hour.  Following a quick water rinse, the samples were 
serially dehydrated with 70%, 85%, 95%, 100%, and 100% ethanol, each for 10 
minutes on a shaker.  The samples were then dried using a critical point dryer 
(Polaron, Watford, England). 
All samples to be examined for SEM were coated with gold using a 108 auto 
sputter coater (Cressington Scientific Instruments, Valencia, PA).  The samples were 
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examined with a Philips XL series SEM, at 5 kV of acceleration voltage, spot 3 of 





3.3.1  Characterization of decellularized liver matrices 
The decellularization procedure produced white, sponge-like tissues (Figure 
3.1).  The procedure also led to a significant reduction in tissue volume, presumably 
due to the removal of cellular contents. 
H&E staining showed that the decellularized matrices were devoid of 
cytoplasm or nuclei staining, indicating a complete removal of the cellular 
components (Figure 3.2).  Correspondingly, no MTS activity or DNA content was 
detected with the decellularized tissues (data not shown). 
On the other hand, the liver tissue structure and vascular network appeared to 
be at least partially preserved.  The removal of liver cells left behind a mesh formed by 
fiber-like structures.  In addition, many central veins and portal triads were discernable 
in the decellularized matrices (Figure 3.2).  However, these structures were much 
closer to each other than in normal livers, further demonstrating the tissue shrinkage 
after removal of liver cells. 
SEM showed that the decellularized matrices were highly porous and non-
homogenous (Figure 3.3).  Two types of structures were often observed: networks of 
fibers forming pores of varied sizes, and coral-like features with small (less than 5 µm) 
but more uniform pores. 
 









Figure 3.1  Appearance of liver tissues before (A) and after (B) decellularization.  The 





















Figure 3.2  H&E staining of liver tissues before (A) and after (B) decellularization.  
Structures of central veins (CV) and portal triads (PT) were preserved.  Magnification 
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Figure 3.3  SEM of decellularized liver matrices.  The matrices were porous and non-
homogenous (A), containing networks of fibers forming pores of varied sizes (B) and 
coral-like features with small but more uniform pores (C).  Scale bar = 50 µm (A) or 
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3.3.2  Fetal liver cell culture on scaffolds 
Experiments in this section compared the growth and differentiation of E14.5 
mouse fetal liver cells cultured on decellularized liver matrices, collagen scaffolds, 
and PLGA scaffolds.  As mentioned earlier, the structure of decellularized matrices 
was heterogeneous.  In contrast, collagen matrices and PLGA scaffolds possessed 
more defined porous structures, with pore size at 100 – 200 µm (provided by product 
manufacturers) and 125 – 250 µm, respectively (Figure 3.4). 
 
Cell distribution on scaffolds 
After two weeks of culture, substantially more cells were detected on PLGA 
scaffolds than on collagen or decellularized matrices (Figure 3.5).  In all cases, the 
majority of the cells were distributed on the surfaces of the scaffolds, forming one or 
more cell layers.  On decellularized matrices, the cells that did penetrate the matrices 
did not seem to have preferred attachment sites: they adhered to the filamentous 
networks as well as to the lumen of vascular structures. 
SEM showed that, in two weeks, cell layers completely covered the surfaces of 
PLGA scaffolds and partially covered those of collagen scaffolds.  Cells in these 
layers appeared to be relatively flat and displayed the characteristic polyhedral shape 
of hepatocytes (Figure 3.6).  Cells on the decellularized matrices were more scattered, 
and appeared to be more heterogeneous: both flat, spread-out and round, compact cells 
with the polyhedral shape were observed. 
 
Cell growth 
Both DNA assay and MTS assay showed that the fetal liver cells continued to 
proliferate over two weeks on all three matrices (Figure 3.7).  However, cell growth 
was more rapid on PLGA scaffolds.  At the end of a 13-day culture period, the DNA  
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Figure 3.4  Structures of decellularized liver matrices (A)
5, collagen matrices (B), and 










                                                 
5  Figure 3.4A is the same as Figure 3.3A. 
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Figure 3.5  H&E staining of E14.5 fetal liver cells cultured for 2 weeks on 
decellularized liver matrices (A), collagen matrices (B), and PLGA scaffolds (C).  The 
cells are identified by blue-black staining of the nuclei and pink staining of the 
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Figure 3.6  SEM of E14.5 fetal liver cells cultured for 2 weeks on the scaffolds.  Cells 
on PLGA (A) and collagen (B) scaffolds appeared as layers of flat hepatocytes, 
whereas cells on decellularized liver matrices were a mix of flat (C) and three-
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content of cultures on PLGA scaffolds was 1.3 and 4.8 times of those on collagen and 
decelllularized matrices, respectively. 
 
Albumin synthesis 
The total albumin secretion rate increased rapidly during the first week in all 
cultures (Figure 3.8A).  Subsequently, the secretion level of cultures maintained on 
PLGA scaffolds continued to increase at a slower rate.  In contrast, the total secretion 
rate declined and stabilized at a lower level in the cultures on collagen and 
decellularized matrices. 
In cultures maintained on decellularized liver matrices or PLGA scaffolds, the 
specific albumin secretion rate increased during the first 7 days and stabilized at the 
peak level afterwards (Figure 3.8B).  The specific secretion rate of cultures on 
collagen scaffolds remained constant during the first week and declined after that.  
Opposite to what was observed with cell growth, the specific secretion rate of cultures 
on decellularized matrices at day 7 was 2.5 - 2.6 times of those on collagen and PLGA 




Glycogenesis was detected in all cultures, as demonstrated by the presence of 
cells stained for PAS (Figure 3.9).  Quantitative analysis needs to be performed in the 
future to compare the extent of glycogenesis on the three scaffolds. 



































































Figure 3.7  Proliferation of E14.5 mouse fetal liver cells as measured by DNA assay 
(A) and MTS assay (B) when cultured on decellularized liver matrices (DCL), 
collagen matrices (CO), and PLGA scaffolds (PLGA). 
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Figure 3.8  Albumin secretion of E14.5 mouse fetal liver cells cultured on 
decellularized liver matrices (DCL), collagen matrices (CO), and PLGA scaffolds 
(PLGA), as indicated by the total secretion rate (µg albumin/well-day, A) and the 
specific secretion rate (µg albumin/µg DNA-day, B). 

















Figure 3.9  Glycogenesis of E14.5 mouse fetal liver cells cultured for 2 weeks on 
decellularized liver matrices (A), collagen scaffolds (B), and PLGA scaffolds (C).  
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3.4 DISCUSSION 
 
3.4.1 Decellularized  liver  matrices 
Results from this study demonstrated that the decellularization method 
described here can efficiently remove the cellular components of liver tissues.  As has 
been observed with other decellularization procedures 
28, 39, removal of the liver cells 
leaves behind a three-dimensional, porous matrix.  However, this study is among the 
first to characterize the structures of the matrix in detail.  Histology analysis showed 
that the matrix is an intricate network formed by fiber-like, non-cellular elements 
(Figure 3.2).  Further analysis is required to determine whether these elements are the 
connective tissue fibers of the liver 
26, the capillary network 
39, or a combination of 
both.  However, it is clear that larger anatomical structures, such as the central veins 
and portal triads, are preserved.  Furthermore, SEM imaging (Figure 3.3) showed that 
the observed network of fibers is not homogeneous, and contains at least two types of 
structures: networks of fibers forming pores with varied sizes, and coral-like features 
with small but uniform pores.  Further analysis is required to determine the origin of 
these structures. 
Cell culture experiments showed that mouse fetal liver cells can attach and 
proliferate on the decellularized liver matrices.  However, cell growth was much 
slower than on collagen matrices and PLGA scaffolds (Figure 3.7).  Previous studies 
also showed that adult hepatocytes cultured on decellularized liver matrices possess 
lower growth capacity than under other conditions (e.g. collagen sandwich) 
28.  The 
observed variation in cell proliferation could be a result of the different chemical and 
physical properties of the scaffolds.  In addition, the slow cell growth on 
decellularized liver matrices may be partially due to inefficient cell attachment, 
possibly caused by the denaturation or removal of binding sites in the matrices by the 
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decellularization procedure.  It is also possible that, even with the extensive washings 
performed here, the decellularized matrices still contained residual detergents that 
inhibited cell growth.  Further optimization of the decellularization method is required 
to address these issues. 
The liver tissue structure preserved in the decellularized matrices did not seem 
to guide cell organization, as the cells did not show preference in attachment sites.  
This is consistent with a previous report that hepatocytes do attach to biomatrices 
derived from other organs such as the aorta and mammary glands, although the cells 
express less differentiated functions than on the liver biomatrix 
40.  Therefore, to take 
advantage of the architectural template provided by a decellularized matrix, alternative 
seeding methods would be required to restrict the fetal liver cells away from the lumen 
of blood vessels 
39. 
 
3.4.2  Differential cellular responses to the scaffolds 
As described in Chapter 2, when fetal liver cells are cultured in medium DD on 
a 2D surface, albumin synthesis increases along with DNA content, presumably due to 
the continual generation, proliferation, and differentiation of hepatocyte precursors.  
However, this was not the case when the cells were cultured on the 3D matrices tested 
in this study.  The decellularized matrices, which did not support efficient cell growth, 
led to higher specific albumin secretion rate than the other two scaffolds (Figures 3.7 
and 3.8).  These results suggested that, in addition to the soluble signals provided in 
the medium, the culture substrata also play an important role in regulating the growth 
and differentiation of fetal liver cells and can even alter their responses to soluble 
signals. 
Although the three types of matrices tested in this study cannot be compared 
systematically due to their drastically different compositions and architectures, a 
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qualitative inspection of their properties still yields clues to how the scaffolds may 
affect the fetal liver cells.  First, significant morphological changes were observed 
with the PLGA scaffold during the experiments.  At the end of a 2-week culture 
period, the PLGA scaffold appeared to be thinner and its diameter decreased by almost 
50%.  In addition, the scaffold became irregular in shape.  In contrast, no noticeable 
changes were observed with the decellularized and collagen matrices.  These 
observations implied that the three types of matrices may differ in their degradation 
rates.  Second, although the mechanical properties of the scaffolds were not quantified, 
the PLGA and collagen scaffolds appeared to be much more rigid than the 
decellularized matrix.  Taken together, it appeared that, in addition to its chemical 
composition and surface chemistry, the mechanical and degradation properties of a 3D 
scaffold might also contribute to regulating the proliferation and maturation of fetal 
liver cells.  Since these properties are easier to adjust in synthetic scaffolds than in 
decellularized and collagen matrices, it would be interesting to see if the fetal liver 
cells are indeed affected when the scaffold properties are altered. 
In summary, the three types of scaffolds tested in this study did not appear to 
be ideal for fetal liver cell culture, as none of them could support both efficient growth 
and differentiation.  The results also hinted at the importance of the scaffold 
properties.  Further investigations using synthetic scaffolds will help to elucidate their 
effects and to define the optimal culture substrates for fetal liver cells, which can 
potentially incorporate the desirable properties of both natural and synthetic materials. 
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 CHAPTER 4 
EFFECTS OF SCAFFOLD PROPERTIES ON THE DEVELOPMENT OF 




In the past several decades, much effort has been directed towards designing 
scaffolds with optimal properties for liver tissue engineering.  In particular, many 
studies have focused on tailoring the surface characteristics of the materials to control 
their interactions with hepatocytes 
1-3.  On the other hand, the bulk properties such as 
mechanical strength and degradation behaviors are primarily designed to provide the 
required growth space and mechanical support during tissue generation 
4, 5.  However, 
numerous studies have shown that these properties also play an important role in 
regulating the morphology, aggregation, growth, and function of adult hepatocytes 
6-8, 
and therefore should be taken into consideration to control the cell-matrix interactions. 
As for fetal liver cells, research regarding their tissue engineering applications 
has been limited.  Moreover, in the studies reported so far, although biochemical 
signals such as OSM were supplemented to suit the developmental needs of fetal liver 
cells, the scaffold materials were adopted from adult hepatocyte cultures without 
modifications 
9-13.  As demonstrated in Chapter 3, the culture substrates do influence 
the behaviors of fetal liver cells and can even alter their responses to soluble signals.  
Therefore, it is vital to characterize the substrate-induced responses of fetal liver cells 
and tailor the material properties to achieve the desired cell behavior. 
Similar to observations with adult hepatocytes, results from Chapter 3 implied 
that the mechanical and degradation properties of a 3D scaffold might also contribute 
to its regulation of fetal liver cells.  The study presented in this chapter would attempt 
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to investigate this issue in further details using PLGA (50:50), polycaprolactone 
(PCL), and their blends at various ratios.  Like PGA and PLA, PCL is a biodegradable 
polyester due to the susceptibility of its aliphatic ester bonds to hydrolysis.  However, 
it degrades at a considerably slower rate and exhibits more elasticity than its poly(α-
hydroxy acids) counterparts.  Due to these characteristics, PCL has been combined 
with other polymers in the form of copolymers or blends for various applications 
14-17.  
In this study, PLGA, PCL and their blends served as model systems to evaluate the 
effects of scaffold properties on fetal liver cells.  First, the properties of the materials 
were characterized.  Scaffolds prepared from these polymers were then used for fetal 
liver cell culture and were evaluated for their impact on cell behaviors including cell 
distribution, cell growth, and differentiation. 
 
 
4.2  MATERIALS AND METHODS 
 
4.2.1  Preparation of polymer scaffolds 
Polymer scaffolds were prepared from PLGA (50:50, Mw ~ 84,000, 
Birmingham Polymers, Pelham, AL), PCL (Mw ~ 65,000, Mn ~ 42,500, Sigma, St. 
Louis, MO), or PLGA/PCL blends using the salt leaching technique.  PLGA and PCL 
were dissolved in chloroform overnight to prepare 5% (w/v) solutions.  The solutions 
were mixed at varied ratios to prepare PLGA/PCL (75/25), PLGA/PCL (50/50), and 
PLGA/PCL (25/75) blends.  Scaffolds were prepared from these polymer solutions as 
described in Chapter 3 (section 3.2.2), except that the size of the NaCl particles used 
in this study was 250 - 425 um and 0.4 g of NaCl was used per scaffold. 
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4.2.2  Test of degradation rate 
The polymer scaffolds were pre-wet with 70% ethanol and coated with 
collagen as described in Chapter 3 (section 3.2.4).  The coated scaffolds were rinsed 
twice with deionized water, blotted dry, and lyophilized.  The weight and dimensions 
(diameter and thickness) of the dried scaffolds were recorded.  Each scaffold was then 
placed in 1 ml/well of DPBS + 1% antibiotic-antimycotic in a nontreated 12-well 
plate, and incubated in a cell culture incubator.  The solution was changed every 2 – 3 
days.  At designated time points, the scaffolds were removed from the plate, rinsed 
twice with deionized water, blotted dry, and lyophilized.  The dimension and weight 
of these scaffolds were measured and compared with the initial values. 
 
4.2.3  Test of hydrophilicity 
The hydrophilicity of the scaffolds was evaluated in two tests.  In the first test, 
the ability of water to wet the scaffolds was determined.  The dry scaffolds were 
weighed, and placed in a bacterial grade petri dish.  One hundred thirty microliters of 
water was added to the surface of the scaffolds in a drop-wise fashion.  After 10 
minutes to allow the water to absorb, the scaffolds were held vertically and shaken to 
remove the unabsorbed water.  The scaffolds were weighed again to determine the 
amount of water that was absorbed. 
In the second test, the contact angles of the polymers with water were 
measured.  Polymer films were used instead of the 3D scaffolds to simplify the 
measurement.  Polymer solutions, prepared as described in section 4.2.2, were added 
to a glass slide at 0.1 – 0.2 ml/slide.  The solution was spread over the slide using a 
glass Pasteur pipette to form a thin polymer layer.  While the layer was still tacky, 
another 0.2 – 0.3 ml of solution was spread onto the slide to ensure that the polymer 
film completely covered the slide.  The slides were left in fume hood overnight to 
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allow the solvent to evaporate.  Subsequently, some of the slides were pre-wet with 
70% ethanol and coated with collagen as described in Chapter 3 (section 3.2.4).  Both 
the uncoated and collagen-coated slides were lyophilized before contact angle 
measurement.  The contact angle measurement was performed using a goniometer 
(Rame-Hart, Mountain Lakes, NJ), with a water droplet size of 2 mm. 
 
4.2.4  Culture and characterization of fetal liver cells on scaffolds 
Fetal liver cells were isolated and processed as described in Chapter 2 (section 
2.2.2).  The polymer scaffolds were pretreated for cell culture as described in Chapter 
3 (section 3.2.4).  The processed fetal liver cells were resuspended in incomplete DD 
culture medium at a concentration of 5X10
6 cells/ml.  Each scafold was seeded with 
200 µl of the cell suspension and cultured as described in section 3.2.4.  
Characterization of the cultures, including cell growth, hepatocyte functions, 
histology, PAS staining, as well as SEM imaging, were all performed as described in 





4.3.1  Characterization of PLGA/PCL scaffolds 
 
Scaffold morphology 
Scaffolds prepared from PLGA, PCL, and their various blends all showed 
similar architecture (Figure 4.1).  All scaffolds exhibited high porosity, with 
rectangular pores mostly 200 - 400 µm in size. 




A  200 µm B 200 µm
E  200 µm
200 µm 200 µm D C 
 
Figure 4.1  SEM of scaffolds prepared from PLGA(A), PLGA/PCL (75/25) (B), 
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Hydrophilicity 
PLGA, PCL, and their blends were all relatively hydrophobic, as indicated by 
their high contact angles with water (Figure 4.2A).  PLGA had the lowest contact 
angle among all at 73.5 ± 1.4°.  When it was blended with PCL, the contact angle 
increased as the percentage of PCL (%PCL) increased from 0% to 50%.  PLGA/PCL 
blends with 50% or more PCL had similar contact angles as pure PCL. 
Collagen coating rendered the polymers more hydrophilic, as demonstrated by 
the decreases in their contact angles (Figure 4.2A).  However, the reductions were less 
dramatic than what was previously reported 
3, probably due to differences in collagen 
concentration and coating method.  Nevertheless, the coating seemed to mask the 
hydrophilicity variations observed with the uncoated polymers, as the contact angles 
of the coated materials were not significantly different. 
Since the polymers were utilized in the form of porous scaffolds for fetal liver 
cell cultures, the hydrophilicity of the scaffolds was tested by their ability to absorb 
water (Figure 4.2B).  The collagen-coated scaffolds were able to absorb water of 3.6 – 




When incubated in DPBS, the PLGA scaffold exhibited the most rapid 
reductions in mass, diameter, and thickness among all samples (Figure 4.3).  Blending 
PLGA with PCL slowed down the decrease of mass and dimension, with the rate of 
decrease inversely correlated with %PCL. 
For scaffolds with more than 50% PLGA, their dimensions decreased far more 
dramatically than their masses.  For example, the PLGA scaffold lost 4% of its mass 
after 3 weeks, whereas its diameter and thickness were reduced by 53% and 26%,  
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ure 4.2  Hydrophilicity of polymers with varied PLGA/PCL content, as assessed by 
compared with PLGA/PCL(100/0). 
PLGA/PCL Content












































water contact angle analysis of the polymer films before and after collagen coating 
(A), and water absorption of collagen-coated scaffolds (B).  “*” indicates p < 0.05 












Figure 4.3  Degradation of scaffolds with varied PLGA/PCL content, as assessed by 
changes in mass (“W”, A), dimension (“D”, B), and thickness (“T”, C).  The values at 
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respectively.  The masses and dimensions of PLGA/PCL (25/75) and PCL scaffolds 
ained almost unchanged over 3 weeks. 
 
4.3.2  Responses of the fetal liver cells to PLGA/PCL scaffolds 
 
Scaffold appearances and cell distribution 
The morphology of scaffolds seeded with fetal liver cells changed in a similar 
way as that of their unseeded counterparts (Figure 4.4).  After 3 weeks of culture, 
increasing level of dimension reduction was observed with higher percentage of 
LGA).  The PLGA and PLGA/PCL (75/25) scaffolds also became irregular 
in shape.  The appearance of PLGA/PCL (25/75) and PCL scaffolds did not change 
noticeably.  In addition, as the culture proceeded, increasing amount of ECM fibers 
was observed projecting from all the scaffolds (Figure 4.5). 
H&E staining showed that, when cultured on the PLGA scaffold, fetal liver 
cells penetrated the scaffold during the first 2 weeks but retreated mostly to the 
scaffold surface by day 21 (Figure 4.6).  On scaffolds prepared from PLGA/PCL 
nds or PCL, however, the cells were observed penetrating the scaffolds and lining 
the pores throughout the culture period.  This observation was confirmed by SEM 
analysis (Figure 4.7).  By day 7 of culture, the fetal liver cells had formed a confluent 
layer that covered the surface of the PLGA scaffold, rendering its pore structure 
largely invisible.  In contrast, the other scaffolds remained porous throughout the 21-
day culture period, with the cells residing both outside and within the pores, forming 
cell layers and aggregates.  On all scaffolds, many cells were found displaying the 
polyhedral shape characteristic of hepatocytes.  The cell size of these presumed 












Figure 4.4  Appearance of PLGA/PCL scaffolds seeded with E14.5 mouse fetal liver 
cells after 3 weeks of culture.  The PLGA/PCL content of the scaffolds ranged from
100/0 (A), 75/25 (B), 50/50 (C), 25/75 (D), to 0/100 (E).  The brown color seen in 





















Figure 4.5  ECM fibers extended out from all PLGA/PCL scaffolds seeded with E14.5 
mouse fetal liver cells.  Representative images were shown here (day-14 cultures).  

























Figure 4.6  H&E staining of E14.5 fetal liver cells cultured for 15 days (A1) and 21 
ays (A2) on PLGA scaffolds, or for 15 days on scaffolds with PLGA/PCL content of 


















Figure 4.7  SEM of E14.5 fetal liver cells cultured for 21 days on scaffolds with 
PLGA/PCL content of 100/0 (A), 75/25 (B), 50/50 (C), 25/75 (D), and 0/100 (E).  
Hepatocytes on the scaffolds appeared to be either flat (F) or three-dimensional (G) 
with cell size ranging from < 10 µm to 40 µm.  Local deformation of the scaffold 
could be observed at scaffold-cell contact points (H – I).  Scale bar = 100 µm (A – E), 
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A 100 µm 
E 100 µm 
C 100 µm  D 100 µm 
B 100 µm 
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Figure 4.7 (Continued).
F  10 µm  G 5 µm 




states.  At high magnification, local deformation of the scaffold caused by the cells 
could be observed. 
 
Cell growth 
All scaffolds supported continuous cell growth during the first week of culture 
(Figure 4.8).  Subsequently, the total DNA content reached a plateau on PLGA, 
PLGA/PCL (25/75), and PCL, but continued to increase for another week on 
PLGA/PCL (75/25) and PLGA/PCL (50/50).  At the end of a 21-day culture, cell 
expansion (based on the fold of increase in DNA content) on PLGA/PCL (75/25) and 
PLGA/PCL (50/50) scaffolds was 1.6 - 2.5 times of that on the others. 
During the first week, cell growth appeared to be inversely correla he 
%PCL of the scaffolds: cellular DNA content was the highest on PLGA scaffolds and 
decreased linearly as the scaffolds contained increasing amount of PCL (Figure 4.8A).  
The growth response became parabolic thereafter: DNA content and MTS activity 
were the highest on scaffolds with 25% - 50% PCL, but decreased when the %PCL 
was outside of this range. 
 
Albumin synthesis 
On all scaffolds, the total albumin secretion rate peaked at day 8 – 10.  
Afterwards, the secretion rate was stabilized at a lower level on scaffolds with 50% or 
more PCL (Figure 4.9A).  In contrast, the secretion level decreased continuously on 
PLGA and PLGA/PCL (75/25).  The change of total secretion level versus PLGA/PCL 
content showed a similar trend as cell growth: during the first week, the secretion level 
was the highest on PLGA scaffolds, and decreased in a linear manner as the scaffolds 
contained more PCL.  In the following 2 weeks, however, a parabolic response to  





Figure 4.8  Proliferation of E14.5 mouse fetal liver cells as measured by DNA assay 
(A) and MTS assay (B) when cultured on scaffolds with varied PLGA/PCL content.  
“*” and “+” indicate p < 0.05 compared with cultures on PLGA/PCL(100/0) and 
PLGA/PCL(75/25) scaffolds, respectively. 
Day in Culture





















































































































































PLGA/PCL(0/100) scaffolds, respectively. 
 
Figure 4.9  Albumin secretion of E14.5 mouse fetal liver cells when cultured on 
scaffolds with varied PLGA/PCL content, as indicated by the total secretion rate (µg 
albumin/well-day, A) and the specific secretion rate (µg albumin/µg DNA-day, B).  
“*” and “+” indicate p < 0.05 compared with cultures on PLGA/PCL(100/0) and 
Day in Culture
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%PCL was again observed.  Blending PLGA with 25% - 50% PCL led to the highest 
secretion level, further increase or decrease of %PCL both led to reduced secretion. 
On the other hand, the addition of PCL appeared to have a favorable effect on 
the specific albumin secretion rate (Figure 4.9B).  Although 
was similar on all scaffolds during the first week, it increased almost linearly with 
%PCL thereafter.  Furthermore, the specific secretion rate declined after about 10 days 




Glycogen-accumulating cells were detected in all cultures, as demonstrated by 
PAS staining (Figure 4.10).  The percentage of stained cells increased over time on all 
scaffolds.  Quantitative analysis needs to be performed in the f ture to determine the 




This study employed blends of PLGA/PCL as a model system to examine the 
influences of scaffold properties on fetal liver cells.  Variation of the scaffold’s 
relative content of PLGA and PCL induced differential cellular responses in a time-
dependent manner.  Initially, cell proliferation was more rapid in the presence of 
growth was obtained on scaffolds containing intermediate amount (25% - 50%) of 
PCL.  On the other hand, the specific albumin secretion rate was enhanced with 
the specific secretion rate 
u
PLGA but down-regulated by PCL.  However, as the culture proceeded, maximal cell 
increasing %PCL. 
 




Figure 4.10  Glycogenesis of E14.5 fetal liver cells cultured for 2 weeks on scaffolds 
with PLGA/PCL content of 100/0 (A), 75/25 (B), 50/50 (C), 25/75 (D), and 0/100 (E).  
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It has been suggested that cell adhesion strongly depends on the hydrophilicity




ers possessed similar wettability after collagen coating, as attested by both 
ontact angle analysis and water absorption test.  Furthermore, past experiments 
ls synthesized large amount of ECM when cultured on 2D 
surface
riations in long-term culture. 
When incubated in DPBS for 3 weeks, the PLGA scaffold lost only 4% of its 
ass, but its diameter and thickness were reduced by 53% and 26%, respectively.  It is 
ters undergo bulk degradation.  In this process, cleavage of 
the pol





s incubated in DPBS for more than 1 week became more fragile 
18-20.  In this study, contact angle analysis indicated that PCL was 
 more hydrophobic than PLGA (50:50).  Consequently, the PLGA/PCL blends 
were less hydrophilic than PLGA.  However, the variation in hydrophilicity was not 
likely the primary cause of the observed cell behavior: first, scaffolds containing 50
or more PCL exhibited similar contact angles as pure PCL, but they led to 
significantly different growth and differentiation kinetics.  In addition, all the 
polym
c
showed that fetal liver cel
s (data not shown).  In 3D culture experiments, all scaffolds were found to 
project increasing amount of ECM fibers as the culture proceeded (Figure 4.5).  
Therefore, it is possible that the fetal liver cells deposited their own ECM on the 
scaffolds, further masking the hydrophilicity va
m
known that aliphatic polyes
ymer backbone, which leads to decreases of molecular weight (MW) and 
mechanical strength, precedes mass loss 
21.  PLGA(50:50) has a degradation tim
- 2 months (provided by the product manufacturer).  The PLGA scaffold used in this
study may degrade even faster, as its highly porous structure allows water access 
the scaffold’s interior.  Hence, the PLGA scaffold’s rapid reduction in dimension 
could be caused by the degradation-associated loss of mechanical strength, which le
to a collapse of the pore structures.  This postulation is consistent with the observ
that PLGA scaffold
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and broke more easily during handling.  However, it needs to be confirmed by analysis 
f the hydrolyzed scaffolds for changes in MW and mechanical properties. 
Consistent with previous reports 
22, 23, the mass loss of PCL was much slower 
than that of PLGA.  Not surprisingly, blends of PLGA and PCL demonstrated erosion 
properties that varied between these two extremes, with less mass loss at increased 
%PCL.  More importantly, incorporation of the slow-degrading PCL alleviated the 
reduction of the scaffold’s dimension, possibly by preventing the rapid loss of 
mechanical strength that preceded th ass loss.  At present, it is not kno
the observed phenomenon was contributed so
slower degradation of PLGA in the presence of PCL. The PLGA (50:50) utilized in 
this study has a Young’s modulus of 1 – 3 X 10
6 kPa, whereas the modulus of PCL is 
an order of magnitude lower at 2 – 3 X 10
5 kPa (provided by product manufacturers).  
Although the mechanical properties of the scaffolds are yet to be quantified, it did 
appear that the materials becam liable with increasing %PCL and decreasing 
%PLGA.  Hence, it is plausible that blending PLGA and PCL at different ratios 
created a series of substrates with systematically varied mechanical and degradation 
properties. 
Based on the above analysis, it is possible that the mechanical and degradation 
characteristics of the scaffolds regulated the growth and differentiation of fetal liver 
cells in multiple ways.  In the e  of the culture, scaffolds with higher %PLGA 
and presumably higher Young’s modulus supported better cell growth.  This is similar 
rigid substrates promote the proliferation of fibroblasts 
 PLGA.  This likely 
 the scaffold surface, sealing off the pores and cutting off 
o
e m wn whether 
lely by PCL, or in conjunction with a 
e more p
arly stage
to previous observations that 
and preosteoblasts 
24, 25.  As the culture proceeded, the degradation-associated loss of 
mechanical strength, combined with the traction forces exerted by the cells 
26-31, 
caused a collapse of the pore structures in scaffolds prepared from
led the cells to spread on












t supply to the cells that might have grown into the pores earlier.  The addition 
of PCL reduced the loss of mechanical strength and thus preserved the pore structures
which benefited cell expansion by enhancing mass transport and providing increased 
growth area.  Consequently, scaffolds with higher stiffness but remained porous, such
as PLGA/PCL (75/25) and PLGA/PCL (50/50), promoted the best cell growth over 
the 3-week culture period.  On the other hand, increasing the %PCL of the 
which presumably decreased its Young’s modulus, promoted the albumin secr
fetal liver cells in an almost linear fashion.  This is consistent with previous studie
a wide range of cell types, which showed that the expression of differentiated 
functions is favored on more compliant substrates 
7, 8, 25, 32-34. 
Increasing evidences suggest that anchorage-dependent cells respond to the
substrate via an “inside → outside → in” feedback loop that couples the cellular 
responses to the stiffness of the
 matrix: as the cells adhere, part of the contractile 
forces generated by the actin/myosin
 microfilaments are transmitted to the sub
 adhesion complexes (referred
 to as traction forces), causing local deformation
of the substrate depending on its stiffness.  In turn, the cells sense the level of matrix 
resistance and respond by adjusting cellular responses such as adhesion, morphology, 
migration, growth, and differentiation 
35-37.  For differentiated cell types such as 
endothelial cells, it has been suggested that substrates with high resistance elevate cell 
traction forces and promote cytoskeleton reorganization that may result in large-scale
cell shape changes.  These events drive the progression through the G1/S restriction 
point and entry into the S phase of the cell cycle.  The cell cycle progression also 
increases the cell’s responsiveness to soluble mitogens, resulting in enhanced cell 
proliferation.  In contrast, softer substrates do not promote this series of actions and 
hence lead to differentiation and enhanced tissue-specific functions 
24, 38, 39.  Findings
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from this and other studies 
25, 37 suggest that the proposed mechanism may also extend 
to less mature cells such as fetal cells and progenitor cells. 
In summary, the PLGA/PCL model system provided insights on the important 
role of 3D scaffolds in regulating the development of fetal liver cells.  The findings 
suggested that cell expansion requires rigid, porous scaffolds with appropriate 
degradation rate, while differentiation is enhanced on more pliable substrates.  In the
future, it would be worthwhile to design test systems with decoupled mechanic
degradation properties so that the individual effects of these parameters could be 
examined.  Findings from these studies will not only help to design optimal culture 
systems for fetal liver cells, but may also provide useful information for applications
of other stem cells and progenitor cells. 
Finally, this study illustrated the feasibility of pairing a fast-degrading, rigid 
material and a slow-degrading, pliable material to support optimal growth and 
differentiation.  For example, PLGA/PCL (50/50) supported efficient cell proliferation
(Figure 4.8), whereas PLGA/PCL (25/75) led to high albumin synthesis (Figure 4








nitially provide a rigid substrate that encourages cell expansion while 
maintaining its structural integrity.  In later stages, the scaffold would become more 
pliable and hence promote maturation of the expanded cells.  This approach may be 
especially beneficial to applications involving stem cells and progenitor cells, given 
their inherently high capacity to proliferate and differentiate. 
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 CHAPTER 5 
CONCLUSIONS 
 
Fetal liver cells, which contain a high percentage of live
 
r progenitors, possess 
e 
an alter icient 
ber  
necessa
maturation.  This thesis explored the influences of several culture variables in order to 




regard  ffective as previously reported.  
of 
fetal liv sent, but 
also by culture to induce 
continu  presence of 
in 
improv e addition of 
he 
presenc
growth and differentiation.  Based on these findings, a modified culture medium was 
high growth potential and can readily repopulate the liver.  Hence, they may provid
native cell source for liver tissue engineering.  In order to generate suff
num  of functional hepatocytes from fetal liver cells for clinical applications, it is
ry to establish a culture system that supports their optimal expansion and 
identify properties that lead to control of the proliferation and differentiation of fetal 
lls.  Specifically, the effects of soluble signals and 3D scaffold properties 
ed. 
The effects of biochemical signals were studied in Chapter 2.  A comparison
resentative medium formulations used in current research showed that, with 
to their intended usage, these media are not as e
Subsequently, the study demonstrated that the growth and differentiation kinetics 
er cells are influenced not only by the regulatory factors that are pre
 the timing of their addition.  HGF is required throughout the 
the differentiation of ALB
- stem cells into hepatic precursors and to ensure the 
al proliferation of stem cells and precursors.  The constant
protective agents such as ascorbic acid helps to enhance cell survival, resulting 
ed cell expansion and hepatocyte functions.  Finally, timing of th
maturation factors such as OSM determines the kinetics of cell differentiation.  In t
e of HGF, addition of OSM from the very beginning results in concurrent 
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developed to achieve both optimal growth and differentiation.  In average, cell 
ion in this medium was about 2 fold of that under other conditi expans ons.  At the end 
 
secretio mal values 
engineering was conducted regarding their effectiveness in supporting fetal liver cell 
ultures.  Three representative scaffolds, decellularized liver matrix, collagen scaffold, 
and PLGA scaffold, were compared.  The results showed that these scaffolds did not 
appear to be ideal for fetal liver cell cultures, as none of them could support both 
efficient growth and differentiation.  More importantly, the study demonstrated that 
the culture substrata play an important role in regulating the behavior of fetal liver 
cells and can even alter their responses to soluble signals.  A qualitative inspection of 
the degradation and mechanical characteristics of the matrices further implied that 
these properties, in addition to the scaffold’s chemical composition and surface 
chemistry, might contribute to regulating the proliferation and maturation of fetal liver 
cells. 
Chapter 4 investigated the impact of scaffold properties in more details using 
PLGA, PCL, and their blends as a model system. The findings suggested that, for fetal 
liver cells, cell expansion requires rigid, porous scaffolds with appropriate degradation 
rate, while differentiation is enhanced on more pliable substrates.  In further studies, 
test systems with decoupled mechanical and degradation properties are required to 
determine the individual effects and optimal values of these scaffold parameters.  This 
study also illustrated the feasibility of pairing a fast-degrading, rigid material and a 
slow-degrading, pliable material to support optimal growth and differentiation.  A 
scaffold thus created would initially provide a rigid substrate that encourages cell 
of a 2-week culture period, the total albumin secretion rate and the specific albumin
n rate in medium DD were 2 - 4 and 2 - 3 times of the maxi
obtained with other conditions, respectively. 
In Chapter 3, a general survey of the 3D scaffolds used in liver tissue 
c
   115
expansion while maintaining its stru   In later stages, the scaffold would 
become more pliable and hence p f the expanded cells. 
The in vitro culture of fetal liver cells is a complex and dynamic process due to 







itant proliferation and multi-step differentiation of these populations.  Overall, 
studies presented in this thesis suggested that the behavior of fetal liver cells is 
regulated by both the chemical and physical cues present in their microenvironment. 
Furthermore, they are influenced not only by what regulatory signals are present, but 
also by when the signals are present.  Accordingly, an ideal culture environment 
should be a dynamic integration of biochemical signals and substrate-related signals to 
control the growth and differentiation kinetics of fetal liver cells.  This may also be 
true for other stem cells and progenitor cells with inherently high capacity to 
proliferate a
 